Fluorouracil in Treating Patients With Anal Cancer
Links shared publicly online about this topic
Roche drug keeps patients cancer-free longer | Reuters
reuters.com — “ZURICH (Reuters) - Roche's cancer drug Xeloda enabled elderly patients being treated for colorectal cancer to live free of the disease for longer, the world's largest maker of cancer drugs said on Thursday. A” View full resource at reuters.com
Most Recently Shared on January 21, 2010 at 8:34 am By:
HealthIT Policy Health News and Health IT
Roche drug keeps patients cancer-free longer: ZURICH (Reuters) - Roche's cancer drug Xeloda enabled elderly patien... http://bit.ly/648Mtn
Non-AIDS-Related Cancers Growing Among HIV Patients - Drugs.com MedNews
drugs.com — “Non-AIDS-related cancers such as anal and lung cancer have become more common among HIV patients than among people without HIV since antiretroviral therapies we” View full resource at drugs.com
Most Recently Shared on September 30, 2009 at 10:17 pm By:
Non-AIDS-Related Cancers Growing Among HIV Patients - http://bit.ly/jx1X3
Effects of chemoradiation therapy by using capecitabine on gastric cancer patients
physorg.com — “A research team from Singapore reviewed the outcome of patients with resected gastric cancers treated with capecitabine and radiation compared to 5-fluorouracil with radiation or fluoropyrimidine-based chemotherapy only. They found that survival of patients treated with capecitabine and radiation was ...” View full resource at physorg.com
Most Recently Shared on September 20, 2010 at 5:30 pm By:
PhysOrg Health News Health News
Effects of chemoradiation therapy by using capecitabine on gastric cancer patients http://tw.physorg.com/204200642
3-drug chemotherapy combination increases organ preservation in patients with larynx cancer
physorg.com — “Patients with larynx cancer who received a three-drug combination of docetaxel, cisplatin and 5-fluorouracil (TPF) during induction chemotherapy were more likely to retain larynx function than were patients treated with cisplatin and 5-fluoruracil (PF) alone, according to data from a randomized controlled ...” View full resource at physorg.com
Most Recently Shared on March 24, 2009 at 10:03 pm By:
3-drug chemotherapy combination increases organ preservation in patients with larynx cancer http://tinyurl.com/cz65qj
FDA approves trastuzumab to treat HER2-overexpressing metastatic gastric or gastroesophageal cancer - - Drug Topics
drugtopics.modernmedicine.com — “FDA approved trastuzumab (Herceptin, Genentech) for use in combination with cisplatin and capecitabine or 5-fluorouracil to treat patients with human epidermal growth factor receptor 2-overexpressing metastatic gastric or gastroesophageal junction cancer who have not received prior treatment for metastatic disease.” View full resource at drugtopics.modernmedicine.com
Most Recently Shared on November 16, 2010 at 7:43 am By:
Drugs and Devices OW OW Health
FDA approves trastuzumab to treat HER2-overexpressing metastatic gastric or gastroesophageal cancer: FDA a... http://bit.ly/d8n5Pm #drug
NICE Draft Guidance Recommends Capecitabine For Advanced Gastric Cancer
medicalnewstoday.com — “In draft guidance published, NICE has recommended a new treatment for advanced gastric cancer. Capecitabine (Xeloda, Roche Products) is recommended, in combination with a platinum-based regimen, f” View full resource at medicalnewstoday.com
Most Recently Shared on May 28, 2010 at 4:11 pm By:
MNT Gastrointestinal Health News
NICE Draft Guidance Recommends Capecitabine For Advanced Gastric Cancer http://mnt.to/3DfH #gastrointestinal
Medical News: CIBD: Bone Drug's Jaw Risk Higher in Some Ca Patients - in Meeting Coverage, CIBD from MedPage Today
medpagetoday.com — “CHICAGO -- Although osteonecrosis of the jaw occurred infrequently in cancer patients treated with denosumab (Xgeva), the rate appeared to increase over time in certain subgroups, a retrospective anal” View full resource at medpagetoday.com
Most Recently Shared on December 2, 2011 at 8:30 pm By:
CIBD: Bone Drug's Jaw Risk Higher in Some Ca Patients (CME/CE) http://t.co/83QNesfh
Gastro Medical News about Gastrointestinal Neoplasms
mdlinx.com — “Bax Predicts Outcome in Gastric Cancer Patients Treated with 5-fluorouracil, Leucovorin, and Oxaliplatin Palliative Chemotherapy” View full resource at mdlinx.com
Most Recently Shared on June 1, 2010 at 1:06 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Bax Predicts Outcome in Gastric Cancer Patients Treated with 5-fluorouracil, Leucovorin, and Oxaliplatin Pallia... http://bit.ly/cPbL07 #GI
Oncology Article | Drug Toxicity Polymorphism, Genetic Colorectal Neoplasms
mdlinx.com — “Combinations of polymorphisms in genes involved in the 5-Fluorouracil metabolism pathway are associated with gastrointestinal toxicity in chemotherapy treated colorectal cancer patients” View full resource at mdlinx.com
Most Recently Shared on April 15, 2011 at 5:56 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Combinations of polymorphisms in genes involved in the 5-Fluorouracil metabolism pathway are associate... http://bit.ly/e28anD #oncology
Oncology Medical News about Rectal Neoplasms Polymorphism, Genetic
mdlinx.com — “Thymidylate synthase germline polymorphisms in rectal cancer patients treated with neoadjuvant chemoradiotherapy based on 5-fluorouracil” View full resource at mdlinx.com
Most Recently Shared on February 23, 2010 at 8:00 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Oncology Thymidylate synthase germline polymorphisms in rectal cancer patients treated with neoadjuvant chemoradio... http://bit.ly/9OJqnk
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
HealthIT Policy
Health IT Policy News and Updates
-
Drugs.com
Keeping you up to date with the latest medication news, FDA Medwatch alerts and new drug approvals.
-
PhysOrg Health News
PhysOrg.com Health and Medicine News Stories
Advertisement
